Aurisco Pharmaceutical Co.,Ltd. (605116.SS) SHH

22.50

+0.12(+0.54%)

Updated at December 05 02:19PM

Currency In CNY

Valuation

Market Cap8.42B
Enterprise Value8.59B
P/E Ratio21.26
PEG Ratio3.54
Price/Sales Ratio5.61
Price/Book Ratio3.55
Enterprise/Revenue5.88
Enterprise/EBITDA17.41

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.26
Operating Margin0.3

Management Effectiveness

Return On Assets0.1
Return On Equity0.17

Income Statement

Revenue1.48B
Revenue/Share4.04
Gross Profit844.36M
EBITDA467.76M
Net Income354.79M
Diluted EPS0.89

Balance Sheet

Total Cash1.04B
Total Cash/Share2.59
Total Debt1.05B
Total Debt/Equity0.42
Current Ratio4.3
Book Value Per Share6.32

Price History

52-Week Change6.56
52-Week High26.33
52-Week Low18.7
Moving Average 50 Days22.62
Moving Average 200 Days22.03

Statistics

Average Volume2.19M
Shares Outstanding406.2M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.29
Trailing Annual Dividend Yield1.29
Payout Ratio0.29
Last Split FactorN/A
Last Split DateN/A